22 results on '"Mallen Christian D"'
Search Results
2. The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative study
- Author
-
Simons, Gwenda, Ismail, Nour, Sandhu, Karanbir, Mallen, Christian D., Stack, Rebecca J., Pontefract, Sarah, Raza, Karim, and Falahee, Marie
- Published
- 2022
- Full Text
- View/download PDF
3. Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink.
- Author
-
Scott, Ian C, Whittle, Rebecca, Bailey, James, Twohig, Helen, Hider, Samantha L, Mallen, Christian D, Muller, Sara, and Jordan, Kelvin P
- Subjects
CROSS-sectional method ,NONSTEROIDAL anti-inflammatory agents ,PSORIATIC arthritis ,RESEARCH funding ,RHEUMATOID arthritis ,SCIENTIFIC observation ,ANKYLOSIS ,DISEASE prevalence ,DESCRIPTIVE statistics ,ANALGESICS ,PHYSICIAN practice patterns ,OPIOID analgesics ,GABAPENTIN ,PAIN management ,DRUG prescribing ,SPONDYLOARTHROPATHIES ,CONFIDENCE intervals ,REGRESSION analysis ,PROPORTIONAL hazards models - Abstract
Objectives Despite little evidence that analgesics are effective in inflammatory arthritis (IA), studies report substantial opioid prescribing. The extent this applies to other analgesics is uncertain. We undertook a comprehensive evaluation of analgesic prescribing in patients with IA in the Clinical Practice Research Datalink Aurum to evaluate this. Methods From 2004 to 2020, cross-sectional analyses evaluated analgesic prescription annual prevalence in RA, PsA and axial spondyloarthritis (axSpA), stratified by age, sex, ethnicity, deprivation and geography. Joinpoint regression evaluated temporal prescribing trends. Cohort studies determined prognostic factors at diagnosis for chronic analgesic prescriptions using Cox proportional hazards models. Results Analgesic prescribing declined over time but remained common: 2004 and 2020 IA prescription prevalence was 84.2/100 person-years (PY) (95% CI 83.9, 84.5) and 64.5/100 PY (64.2, 64.8), respectively. In 2004, NSAIDs were most prescribed (56.1/100 PY; 55.8, 56.5), falling over time. Opioids were most prescribed in 2020 (39.0/100 PY; 38.7, 39.2). Gabapentinoid prescribing increased: 2004 prevalence 1.1/100 PY (1.0, 1.2); 2020 prevalence 9.9/100 PY (9.7, 10.0). Most opioid prescriptions were chronic (2020 prevalence 23.4/100 PY [23.2, 23.6]). Non-NSAID analgesic prescribing was commoner in RA, older people, females and deprived areas/northern England. Conversely, NSAID prescribing was commoner in axSpA/males, varying little by deprivation/geography. Peri-diagnosis was high-risk for starting chronic opioid/NSAID prescriptions. Prognostic factors for chronic opioid/gabapentinoid and NSAID prescriptions differed, with NSAIDs having no consistently significant association with deprivation (unlike opioids/gabapentinoids). Conclusion IA analgesic prescribing of all classes is widespread. This is neither evidence-based nor in line with guidelines. Peri-diagnosis is an opportune moment to reduce chronic analgesic prescribing. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Polymyalgia rheumatica
- Author
-
Mackie, Sarah L and Mallen, Christian D
- Published
- 2013
5. Analgesic prescribing in patients with inflammatory arthritis in England: an observational study using electronic healthcare record data.
- Author
-
Scott, Ian C, Bailey, James, White, Christopher R, Mallen, Christian D, and Muller, Sara
- Subjects
NARCOTICS ,CONFIDENCE intervals ,ANALGESICS ,CROSS-sectional method ,AGE distribution ,SEX distribution ,RHEUMATOID arthritis ,ELECTRONIC health records ,PAIN management - Abstract
Objectives International data suggest inflammatory arthritis (IA) pain management frequently involves opioid prescribing, despite little evidence of efficacy, and potential harms. We evaluated analgesic prescribing in English National Health Service-managed patients with IA. Methods Repeated cross-sectional analyses in the Consultations in Primary Care Archive (primary care consultation and prescription data in nine general practices from 2000 to 2015) evaluated the annual prevalence of analgesic prescriptions in: (i) IA cases (RA, PsA or axial spondyloarthritis [SpA]), and (ii) up to five age-, sex- and practice-matched controls. Analgesic prescriptions were classified into basic, opioids, gabapentinoids and oral NSAIDs, and sub-classified into chronic and intermittent (≥3 and 1–2 prescriptions per calendar year, respectively). Results In 2000, there were 594 cases and 2652 controls, rising to 1080 cases and 4703 controls in 2015. In all years, most (65.3–78.5%) cases received analgesics, compared with fewer (37.5–41.1%) controls. Opioid prescribing in cases fell between 2000 and 2015 but remained common with 45.4% (95% CI: 42.4%, 48.4%) and 32.9% (95% CI: 29.8%, 36.0%) receiving at least 1 and ≥3 opioid prescriptions, respectively, in 2015. Gabapentinoid prescription prevalence in cases increased from 0% in 2000 to 9.5% (95% CI: 7.9%, 11.4%) in 2015, and oral NSAID prescription prevalence fell from 53.7% (95% CI: 49.6%, 57.8%) in 2000 to 25.0% (95% CI: 22.4%, 27.7%) in 2015. Across years, analgesic prescribing was commoner in RA than PsA/axial SpA, and 1.7–2.0 times higher in cases than controls. Conclusions Analgesic prescribing in IA is common. This is at variance with existing evidence of analgesic efficacy and risks, and guidelines. Interventions are needed to improve analgesic prescribing in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum.
- Author
-
Nakafero, Georgina, Grainge, Matthew J, Card, Tim, Taal, Maarten W, Aithal, Guruprasad P, Zhang, Weiya, Doherty, Michael, Fox, Christopher P, Mallen, Christian D, and Abhishek, Abhishek
- Subjects
ENZYME analysis ,DRUG therapy for arthritis ,PATIENT aftercare ,CONFIDENCE intervals ,LEFLUNOMIDE ,EPILEPSY ,CALIBRATION ,REGRESSION analysis ,RISK assessment ,DECISION making ,DRUG monitoring ,TERMINATION of treatment ,BLOOD testing ,ARTHRITIS ,PREDICTION models ,MEDICAL prescriptions ,DEATH ,PROPORTIONAL hazards models ,LONGITUDINAL method ,DRUG toxicity ,DISEASE complications - Abstract
Objective To develop and validate a prognostic model for LEF discontinuation with abnormal blood test results. Methods Data from the Clinical Practice Research Datalink Gold and Aurum were used for model development and external validation, respectively. Participants prescribed LEF between 1 January 2007 and 31 December 2019 were followed up from 6 months after the first general practitioner prescription to the earliest of date of outcome, death, 5 year follow-up or 31 December 2019. Candidate prognostic factors were ascertained using theory and data-driven approaches. Penalized Cox regression was performed to develop the risk equation, followed by internal validation using 500 bootstraps to correct for optimism. Multiple imputation was applied to handle missing data. Model performance was assessed in terms of calibration and discrimination. Results Data for 1487 and 2329 participants contributing 3140 and 5246 person-years follow-up were included in the development and validation cohorts, respectively. Thirteen candidate predictors were included in the model. Epilepsy and either cytopenia or elevated liver enzymes during the first 6 months of shared-care LEF prescription were strong predictors of drug discontinuation with a hazard ratio of 4.39 (95% CI 1.74, 11.06) and 3.06 (2.15, 4.35), respectively. The unadjusted and optimism-adjusted calibration slope in development data was 1.00 (95% CI 0.75, 1.25) and 0.72 (95% CI 0.47, 0.97), respectively. The calibration slope in validation data was 0.91 (95% CI 0.74, 1.07). The model showed prognostic separation with an optimism-adjusted Royston D statistic of 0.73 (95% CI 0.44, 1.02). Conclusion We have developed and externally validated an easy-to-use prognostic model that may be used to risk stratify monitoring for LEF toxicity and to make informed choices about risks when choosing treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink
- Author
-
Nakafero, Georgina, Grainge, Matthew J, Myles, Puja R, Mallen, Christian D, Zhang, Weiya, Doherty, Michael, Nguyen-Van-Tam, Jonathan S, and Abhishek, Abhishek
- Subjects
rheumatoid arthritis ,Male ,Vasculitis ,Databases, Factual ,Fever ,Autoimmune Diseases ,RC925 ,Reference Values ,Rheumatic Diseases ,RC927 ,Influenza, Human ,Humans ,Referral and Consultation ,Risk Management ,Primary Health Care ,Vaccination ,Miscellaneous ,Vaccines, Inactivated ,Influenza Vaccines ,Case-Control Studies ,Disease Progression ,Female ,Patient Safety ,Follow-Up Studies - Abstract
Objectives:\ud To examine the association between inactivated influenza vaccine (IIV) administration and primary care consultation for joint pain, rheumatoid arthritis (RA) flare, corticosteroid prescription, vasculitis and unexplained fever in people with autoimmune rheumatic diseases (AIRDs). \ud \ud METHODS: \ud We undertook within-person comparisons using self-controlled case-series methodology. AIRD cases who received the IIV and had an outcome of interest in the same influenza cycle were ascertained in Clinical Practice Research Datalink. The influenza cycle was partitioned into exposure periods (1-14 days prevaccination and 0-14, 15-30, 31-60 and 61-90 days postvaccination), with the remaining time-period classified as non-exposed. Incidence rate ratios (IRR) and 95% CI for different outcomes were calculated. \ud \ud RESULTS: \ud Data for 14 928 AIRD cases (69% women, 80% with RA) were included. There was no evidence for association between vaccination and primary care consultation for RA flare, corticosteroid prescription, fever or vasculitis. On the contrary, vaccination associated with reduced primary care consultation for joint pain in the subsequent 90 days (IRR 0.91 (95% CI 0.87 to 0.94)). \ud \ud CONCLUSION: \ud This study found no evidence for a significant association between vaccination and primary care consultation for most surrogates of increased disease activity or vaccine adverse-effects in people with AIRDs. It adds to the accumulating evidence to support influenza vaccination in AIRDs.
- Published
- 2019
8. Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.
- Author
-
Nikiphorou, Elena, de Lusignan, Simon, Mallen, Christian D., Khavandi, Kaivan, Bedarida, Gabriella, Buckley, Christopher D., Galloway, James, and Raza, Karim
- Subjects
CARDIOVASCULAR diseases risk factors ,RHEUMATOID arthritis ,CORONARY disease ,DISEASE risk factors - Abstract
Objective: To assess the burden of cardiovascular disease (CVD) at and prior to diagnosis in people with early rheumatoid arthritis (RA) and subsequent CVD in these patients.Methods: A retrospective case-control study using a large English primary care database. People with RA (n=6591) diagnosed between 2004 and 2016 (inclusive) were identified using a validated algorithm, matched 1:1 by age and gender to those without RA (n=6591) and followed for a median of 5.4 years. We assessed differences in CVD at, before and after diagnosis, and the impact of traditional and RA-related risk factors (C reactive protein, RA-related autoantibodies and medication use) on incident CVD (a composite of myocardial infarction (MI), stroke or heart failure).Results: RA cases and their matched controls were both of mean age 58.7 (SD 15.5) at cohort entry, and 67.5% were female. Some CVD risk factors were more common at RA diagnosis including smoking and diabetes; however, total and low-density lipoprotein cholesterol were lower in patients with RA. CVD was more common in RA at cohort entry; stroke (3.9% vs 2.7%, p<0.001), heart failure (1.6% vs 1.0%, p=0.001), and non-significantly MI (3.1% vs 2.8%, p=0.092). Excess CVD developed in the 5 years preceding diagnosis. After adjustment for traditional and RA-related risk factors, RA was associated with greater risk of post-diagnosis CVD (HR 1.33, 95% CI 1.07 to 1.65, p=0.010).Conclusions: An excess of stroke and heart failure occurs before diagnosis of RA. There is excess risk for further cardiovascular events after diagnosis, which is not explained by differences in traditional CVD or RA-related risk factors at diagnosis. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
9. Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study.
- Author
-
Nakafero, Georgina, Grainge, Matthew J, Myles, Puja R, Mallen, Christian D, Zhang, Weiya, Doherty, Michael, Nguyen-Van-Tam, Jonathan S, and Abhishek, Abhishek
- Subjects
DRUG therapy for rheumatism ,RHEUMATISM diagnosis ,ANTIRHEUMATIC agents ,INFLUENZA vaccines ,SEASONAL influenza ,AGE distribution ,IMMUNIZATION ,LONGITUDINAL method ,REGRESSION analysis ,RHEUMATISM ,PREVENTION ,VACCINATION ,THERAPEUTICS - Abstract
Objectives To examine temporal trend in uptake of seasonal influenza vaccine (SIV) in the UK and explore disease and demographic factors associated with vaccination. Methods From the Clinical Practice Research Datalink, 32 751 people with auto-immune rheumatic diseases prescribed DMARDs between 2006 and 2016 were identified. The proportion vaccinated between 1 September of one year and 31 March of the next year was calculated and stratified by age, other indications for vaccination, auto-immune rheumatic diseases type and number of DMARDs prescribed. Stata and Joinpoint regression programs were used. Results SIV uptake was high in those aged ⩾65 years (82.3 and 80.7% in 2006–07 and 2015–16, respectively). It was significantly lower in other age groups, but improved over time with 51.9 and 61.9% in the 45–64 year age group, and 32.3 and 50.1% in the <45 year age group being vaccinated in 2006–07 and 2015–16, respectively. While 64.9% of the vaccinations in those ⩾65 years old occurred by 3 November, in time to mount a protective immune response before the influenza activity becomes substantial in the UK, only 38.9% in the 45–64 year and 26.2% in the <45 year age group without any other reason for vaccination received SIV by this date. Women, those with additional indications for vaccination, on multiple DMARDs and with SLE were more likely to be vaccinated. Conclusion SIV uptake is low in the under 65s, and the majority of them are not vaccinated in time. Additional effort is required to promote timely uptake of SIV in this population. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
10. How common is depression in patients with polymyalgia rheumatica?
- Author
-
Vivekanantham, Arani, Blagojevic-Bucknall, Milica, Clarkson, Kris, Belcher, John, Mallen, Christian D., and Hider, Samantha L.
- Subjects
MENTAL depression ,RHEUMATOID arthritis ,SYSTEMIC lupus erythematosus ,POLYMYALGIA rheumatica ,GLUCOCORTICOIDS - Abstract
Depression is common in inflammatory disorders such as rheumatoid arthritis and systemic lupus erythematosus and negatively impacts on outcomes. Given the long-term nature of polymyalgia rheumatica
( PMR) and its glucocorticoid treatment, these patients may be at an increased risk of depression, although few studies exist to date. This study aimed to investigate the prevalence of, and factors associated with, depression in PMR patients. Prevalent PMR patients (with a first diagnostic code for PMR in the last 3 years) were mailed a postal questionnaire (n = 704) examining PMR symptoms, glucocorticoid use and patient reported comorbidities. Depressive symptoms were assessed using the Patient Health Questionnaire-8 (PHQ-8), with a score of ≥10 defined as current depressive symptoms. Logistic regression was used to examine association between demographics, comorbidity and current depressive symptoms. Five hundred fifty (78%) patients responded, of which 365 (66%) were female, with a mean (SD) age of 74.1 years (8.4). The prevalence of current depressive symptoms was 15% (n = 81) and was significantly associated with female gender: OR 1.87 (95%CI 1.08-3.22), current PMR symptoms: OR 2.1 (1.11-3.97), self-reported acid reflux: OR 1.75 (1.05-2.93) and diabetes: OR 2.86 (1.6-5.09). Older patients were less likely to report current depressive symptoms (OR 0.35 (0.13-0.9) for those >80 years versus those aged 50-59 years). Depressive symptoms are common in patients with PMR patients, especially younger patients and those with comorbidities. Clinicians should consider screening these patients for depressive symptoms and managing them appropriately, as untreated depression may negatively impact on health-related outcomes and quality of life. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
11. UK--south Asian patients' experiences of and satisfaction toward receiving information about biologics in rheumatoid arthritis.
- Author
-
Kumar, Kanta, Raizada, Sabrina R, Mallen, Christian D, and Stack, Rebecca J
- Subjects
RHEUMATOID arthritis ,HEALTH of South Asians ,RHEUMATOID arthritis treatment ,PATIENT participation ,MEDICAL cooperation ,PATIENTS - Abstract
Background: Rheumatoid arthritis (RA) causes painful joint inflammation and is incurable, but treatments control RA. Drug regimens are complex, and patients often do not take their medication as expected. Poor medication adherence can lead to poorly controlled disease and worse patient outcomes. Biologics treatments are expensive and require full engagement from patients. We have previously shown that patients from Black ethnic minority backgrounds do not fully engage into treatment plan. This study explored the patients' experiences in and satisfaction toward receiving information about biologics and future support preferences in South Asian patients with RA. Methods: Twenty South Asian patients with RA from Royal Wolverhampton Hospitals NHS Trust and Central Manchester University Hospitals NHS Foundation Trust participated in individual semistructured interviews. Interviews were transcribed and data were analyzed by using thematic analysis approach. Results: Four overarching themes describe the patients' experience in and satisfaction toward receiving information on biologics: 1) current provision of information regarding the "biologics journey" and understanding of RA: in this theme, non-English-speaking patients expressed heightened anxiety about stepping up to biologics; 2) experience and perceptions of biologics: many patients were positive about the biologic experience; however, there were patient-perceived delays in getting on to the biologics; 3) factors influencing willingness to try biologics: in this theme, a number of factors were identified including seeking advice from doctors abroad; and 4) recommendations on the desired information to fully understand the use of biologics: some patients valued group discussions, while others suggested receiving RA and biologic information through a video interaction. Conclusion: This novel study provides insight into South Asian RA patients' experiences in and satisfaction toward receiving information about biologics. South Asian patients with RA reported a range of perceptions about biologics and support preferences, many of which may not be shared with the non-South Asian population. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
12. The pathway to consultation for rheumatoid arthritis: exploring anticipated actions between the onset of symptoms and face-to-face encounter with a healthcare professional.
- Author
-
Simons, Gwenda, Lumley, Sophie, Falahee, Marie, Kumar, Kanta, Mallen, Christian D., Stack, Rebecca J., and Raza, Karim
- Subjects
RHEUMATOID arthritis ,MEDICAL personnel ,SELF-management (Psychology) ,INTESTINAL cancer ,ANGINA pectoris ,JOINT abnormalities ,RHEUMATOID arthritis diagnosis ,COMPARATIVE studies ,DECISION making ,DIAGNOSIS ,RESEARCH methodology ,MEDICAL cooperation ,MEDICAL errors ,PATIENT-professional relations ,MEDICAL referrals ,RESEARCH ,RESEARCH funding ,HEALTH self-care ,QUALITATIVE research ,EVALUATION research ,INFORMATION-seeking behavior ,PATIENTS' attitudes ,PSYCHOLOGY - Abstract
Background: When people first experience symptoms of rheumatoid arthritis (RA) they often delay seeking medical attention resulting in delayed diagnosis and treatment. This research assesses behaviours people might engage in prior to, or instead of, seeking medical attention and compares these with behaviours related to illnesses which are better publicised.Methods: Thirty-one qualitative interviews with members of the general public explored intended actions in relation to two hypothetical RA vignettes (with and without joint swelling) and two non-RA vignettes (bowel cancer and angina). The interviews were audio-recorded and transcribed. Analysis focused on intended information gathering and other self-management behaviours in the interval between symptom onset and help-seeking.Results: Participants were more likely to envision self-managing symptoms when confronted with the symptoms of RA compared to the other vignettes. Participants would look for information to share responsibility for decision making and get advice and reassurance. Others saw no need for information seeking, perceived the information available as untrustworthy or, particularly in the case of bowel cancer and angina, would not want to delay seeking medical attention. Participants further anticipated choosing not to self-manage the symptoms; actively monitoring the symptoms (angina/ bowel cancer) or engaging in self-treatment of symptom(s).Discussion: These results help define targets for interventions to increase appropriate help-seeking behaviour for people experiencing the initial symptoms of RA, such as educational interventions directed at allied healthcare professionals from whom new patients may seek information on self-management techniques, or the development of authoritative and accessible informational resources for the general public. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
13. Rheumatoid arthritis is getting less frequent--results of a nationwide population-based cohort study.
- Author
-
Abhishek, Abhishek, Doherty, Michael, Chang-Fu Kuo, Mallen, Christian D., Weiya Zhang, and Grainge, Matthew J.
- Subjects
COMPARATIVE studies ,CONFIDENCE intervals ,EPIDEMIOLOGICAL research ,LONGITUDINAL method ,POPULATION geography ,PRIMARY health care ,RHEUMATOID arthritis ,STATISTICAL significance ,DESCRIPTIVE statistics - Abstract
Objectives. The objectives of this study were to examine changes in the incidence and prevalence of RA between 1990 and 2014 and to explore if there is any geographic variation in the incidence and prevalence of RA in the UK. Methods. This was a primary care-based prospective cohort study. People contributing acceptable data to Clinical Practice Research Datalink between 1 January 1990 and 31 December 2014 were included. Read codes were used to identify RA cases ≽18 years of age. The prevalence and incidence rates for each year were standardized to the 2014 population and the regional incidence and prevalence of RA for the year 2014 were standardized to the overall population. Results. The incidence and prevalence of RA was 3.81/10 000 person-years and 0.67%, respectively, in 2014. The annual incidence of RA decreased by 1.6% (95% CI 0.8, 2.5) between 1990 and 2014, with significant joinpoints at 1994 and 2002. The prevalence of RA increased by 3.7%/year (95% CI 3.2, 4.1) from 1990 to 2005 and decreased by 1.1%/year (95% CI 2.0, 0.2) between 2005 and 2014. There were significant differences in the occurrence of RA throughout different regions of the UK, with the highest incidence in East Midlands, Yorkshire and Humber and the highest prevalence in North East, Yorkshire and Humber. Conclusion. The incidence of RA is decreasing, with a reduction in prevalence in recent years. There is significant geographic variation in the occurrence of RA in the UK. Further research is required to identify the reasons underlying this phenomenon so that public health interventions can be designed to further reduce the incidence of RA. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
14. Symptom Recognition and Perceived Urgency of Help-Seeking for Rheumatoid Arthritis and Other Diseases in the General Public: A Mixed Method Approach.
- Author
-
Simons, Gwenda, Belcher, John, Morton, Chris, Kumar, Kanta, Falahee, Marie, Mallen, Christian D., Stack, Rebecca J., and Raza, Karim
- Subjects
RECTUM tumors ,RHEUMATOID arthritis diagnosis ,RHEUMATOID arthritis ,COLON tumors ,ANGINA pectoris ,SYMPTOMS ,EXPERIMENTAL design ,HEALTH attitudes ,RESEARCH funding ,QUALITATIVE research ,SELF diagnosis ,PSYCHOLOGY ,DIAGNOSIS - Abstract
Objective: Clinical outcomes in rheumatoid arthritis (RA) are improved if the disease is treated early. However, treatment is often significantly delayed as a result of delayed help-seeking by patients who fail to recognize its symptoms or the need for rapid medical attention. Two studies were conducted to investigate the role of symptom recognition in help-seeking for the symptoms of RA, and compared this to symptom recognition and help-seeking in angina and bowel cancer.Methods: A qualitative interview study with 31 individuals and a survey of 1,088 members of the general public (all without RA) were conducted. Both studies used vignettes describing the symptoms of RA, bowel cancer, and angina. Participants made causal attributions and rated the perceived seriousness of the symptoms and the urgency with which they would seek medical help if confronted with these symptoms.Results: Only a small proportion of participants in both studies recognized the symptoms of RA, whereas the symptoms of bowel cancer and angina were readily recognized by many participants and considered to be more serious and to require more rapid medical attention (Z = 14.7-34.2, P < 0.001).Conclusion: Accurate symptom attribution and the perception that symptoms are indicative of a serious underlying condition are both important drivers for rapid help-seeking. In the case of angina and bowel cancer, recent campaigns have promoted not only recognition of symptoms and their seriousness, but also emphasized the consequences of not seeking timely help. Our results suggest that these consequences should also be addressed in any public health campaign for RA. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
15. Qualitative Exploration of Illness Perceptions of Rheumatoid Arthritis in the General Public.
- Author
-
Simons, Gwenda, Mason, Anna, Falahee, Marie, Kumar, Kanta, Mallen, Christian D., Raza, Karim, and Stack, Rebecca J.
- Subjects
CONCEPTUAL structures ,HEALTH behavior ,HELP-seeking behavior ,INTERVIEWING ,RHEUMATOID arthritis ,SELF-management (Psychology) ,ATTITUDES toward illness - Abstract
Treating patients with rheumatoid arthritis (RA) within three months of symptom onset leads to significantly improved outcomes. However, many people delay seeking medical attention. In order to understand the reasons for this delay, it is important to have a thorough understanding of public perceptions about RA. The current study investigated these perceptions using the Self-Regulation Model (SRM) as a framework to explain how health behaviour is influenced by illness perceptions (prototypes) through qualitative interviews with 15 members of the public without RA. Interviews were audio-recorded, transcribed and analysed using framework analysis based on SRM illness perceptions. Both accurate and inaccurate perceptions about the identity, causes, consequences, controllability and timeline of RA were identified. This highlights opportunities to enhance public knowledge about RA. These findings further support the utility of exploring prototypical beliefs of illness, suggesting their potential role in influencing help-seeking behaviours and identifying probable drivers/barriers to early presentation. © 2016 The Authors Musculoskeletal Care Published by John Wiley & Sons Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
16. The development and initial validation of a questionnaire to measure help-seeking behaviour in patients with new onset rheumatoid arthritis.
- Author
-
Stack, Rebecca J., Mallen, Christian D., Deighton, Chris, Kiely, Patrick, Shaw, Karen L., Booth, Alison, Kumar, Kanta, Thomas, Susan, Rowan, Ian, Horne, Rob, Nightingale, Peter, Herron-Marx, Sandy, Jinks, Clare, and Raza, Karim
- Subjects
- *
RHEUMATOID arthritis diagnosis , *RHEUMATOID arthritis treatment , *BEHAVIOR , *COMMUNICATION , *HEALTH services accessibility , *RESEARCH methodology , *MEDICAL care , *PATIENTS , *QUESTIONNAIRES , *RESEARCH funding , *RHEUMATOID arthritis , *EARLY medical intervention , *DESCRIPTIVE statistics - Abstract
The article presents the study of developing, testing the reliability, and validating test questionnaire to evaluate help-seeking behaviour among patients with rheumatoid arthritis (RA). Methods were designed which include extraction, test-retest survey, and organization of items in various themes including self-management, causal beliefs, and early symptom experience. Results were outlined and conclude the significant RA patients involvement on the development and validation of questionnaire.
- Published
- 2015
- Full Text
- View/download PDF
17. How can primary care physicians enhance the early diagnosis of rheumatic diseases?
- Author
-
Mallen, Christian D., Helliwell, Toby, and Scott, Ian C.
- Subjects
RHEUMATOID arthritis diagnosis ,EARLY diagnosis ,INFLAMMATION ,PRIMARY care ,GENERAL practitioners ,PROGNOSIS - Published
- 2018
- Full Text
- View/download PDF
18. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development.
- Author
-
Stack, Rebecca J., van Tuyl, Lilian H. D., Sloots, Maurits, van de Stadt, Lotte A., Hoogland, Wijnanda, Maat, Bertha, Mallen, Christian D., Tiwana, Rumandeep, Raza, Karim, and van Schaardenburg, Dirkjan
- Subjects
ACADEMIC medical centers ,ALGORITHMS ,BLOOD testing ,INTERVIEWING ,RESEARCH funding ,RHEUMATOID arthritis ,SEVERITY of illness index ,JOINT pain ,DESCRIPTIVE statistics ,SYMPTOMS - Abstract
Objective. The aim of this study was to explore symptoms and symptom development during the earliest phases of RA in patients with seropositive arthralgia and patients newly diagnosed with RA.Methods. Interviews were conducted with 15 seropositive patients (anti-CCP positive, and often with arthralgia) and 11 newly presenting RA patients [classified according to the 2010 ACR/European League Against Rheumatism (EULAR) criteria]. Feedback procedures shared the experiences of seropositive arthralgia patients with early RA patients and vice versa. Data were analysed using thematic analysis.Results. Symptoms common to both groups included joint pain, psychological distress, muscle cramps, abnormal skin sensations, stiffness, loss of motor control, weakness, fatigue and sleeping difficulties. Also, patterns of symptom evolution and the order of symptom development were described. Seropositive arthralgia patients described pain as annoying, while RA patients described how the severity of pain intensified before diagnosis, to the point where symptoms were psychologically distressing. Patients with seropositive arthralgia described reddening of the skin and burning sensations that they felt were indicative of the onset of swelling. Intense pain appeared to precede the onset of swelling for those with RA, which was often palindromic and travelled between joints until it later became persistent.Conclusion. This study highlights the breadth of symptoms that constitute the earliest phases of RA. Further research is needed to develop measures of symptom patterns and clusters to allow the predictive utility of symptoms to be assessed and to allow the integration of aspects of the patient’s history into evidence-based investigative and management algorithms for use in primary and secondary care. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
19. General practitioners' perspectives on campaigns to promote rapid help-seeking behaviour at the onset of rheumatoid arthritis.
- Author
-
Stack, Rebecca J., Llewellyn, Zara, Deighton, Chris, Kiely, Patrick, Mallen, Christian D., and Raza, Karim
- Subjects
HEALTH promotion ,FOCUS groups ,HELP-seeking behavior ,GENERAL practitioners ,PUBLIC health ,RESEARCH funding ,RHEUMATOID arthritis ,TIME ,THEMATIC analysis ,DATA analysis software ,PHYSICIANS' attitudes - Abstract
Objective. To explore general practitioners' (GPs') perspectives on public health campaigns to encourage people with the early symptoms of rheumatoid arthritis (RA) to seek medical help rapidly. Design. Nineteen GPs participated in four semi-structured focus groups. Focus groups were audio-recorded, transcribed verbatim, and analysed using thematic analysis. Results. GPs recognised the need for the early treatment of RA and identified that facilitating appropriate access to care was important. However, not all held the view that a delay in help seeking was a clinically significant issue. Furthermore, many were concerned that the early symptoms of RA were often non-specific, and that current knowledge about the nature of symptoms at disease onset was inadequate to inform the content of a help-seeking campaign. They argued that a campaign might not be able to specifically target those who need to present urgently. Poorly designed campaigns were suggested to have a negative impact on GPs' workloads, and would 'clog up' the referral pathway for genuine cases of RA. Conclusions. GPs were supportive of strategies to improve access to Rheumatological care and increase public awareness of RA symptoms. However, they have identified important issues that need to be considered in developing a public health campaign that forms part of an overall strategy to reduce time to treatment for patients with new onset RA. This study highlights the value of gaining GPs' perspectives before launching health promotion campaigns. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
20. Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study.
- Author
-
Monk, Helen L., Muller, Sara, Mallen, Christian D., and Hider, Samantha L.
- Subjects
CARDIOVASCULAR disease prevention ,MEDICAL screening ,BLOOD pressure ,BLOOD sugar ,BODY weight ,CHI-squared test ,CONFIDENCE intervals ,EPIDEMIOLOGY ,LIPIDS ,PRIMARY health care ,RESEARCH funding ,RHEUMATOID arthritis ,SMOKING ,T-test (Statistics) ,LOGISTIC regression analysis ,DATA analysis ,CROSS-sectional method ,DATA analysis software ,DESCRIPTIVE statistics ,DISEASE complications - Abstract
Patients with rheumatoid arthritis (RA) are known to be at increased risk of vascular disease. It is not known whether screening for vascular risk factors occurs in primary care. The aim of this study was to determine whether guidance advocating cardiovascular screening in RA patients is being implemented in primary care. Methods This study was undertaken in a UK primary care consultation database. All patients with a diagnosis of RA between 2000 and 2008, and still registered with the GP practice in 2009 were matched by age, gender and GP practice to three non-RA patients. Evidence of screening for five traditional vascular risk factors (blood pressure, lipids, glucose, weight, smoking) was compared in those with and without RA using logistic regression models. A comparison was also made with diabetes. Results 401 RA patients were identified and matched to 1198 non-RA patients. No differences in the overall rates of screening were found (all five risk factors: RA 24.9% vs no RA 25.6%), but RA patients were more likely to have a smoking status recorded (67% versus 62%). In contrast, those with diabetes were up to 12 times as likely to receive vascular screening. Despite the excess risk of vascular disease in patients with RA being of a similar magnitude to that seen in diabetes, patients with RA did not receive additional CVD screening in primary care, although this was achieved in patients with diabetes. More emphasis needs to be placed on ensuring those with RA are actively screened for cardiovascular disease in primary care. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
21. Rheumatoid arthritis: what do we mean by early?
- Author
-
Raza, Karim and Mallen, Christian D.
- Subjects
- *
ANTIRHEUMATIC agents , *RHEUMATOID arthritis , *RISK assessment , *SEVERITY of illness index , *EARLY medical intervention - Abstract
The author discusses arthritis medications called disease-modifying antirheumatic drugs (DMARDs) that work by curbing the underlying processes that cause rheumatoid arthritis (RA). A study was conducted to identify that after being diagnosed by RA, the quicker that patient sees a rheumatologist, the better the long-term outcome. The article concludes that the problem arises when one shows symptoms of rheumatoid arthritis, but doesn't meet the criteria for diagnosis.
- Published
- 2013
- Full Text
- View/download PDF
22. Predictors of the likelihood that patients with rheumatoid arthritis will communicate information about rheumatoid arthritis risk to relatives: A quantitative assessment.
- Author
-
Wells, Imogen, Zemedikun, Dawit T., Simons, Gwenda, Stack, Rebecca J., Mallen, Christian D., Raza, Karim, and Falahee, Marie
- Subjects
- *
RHEUMATOID arthritis , *FAMILY communication , *PREDICTIVE tests , *RISK communication , *RELATIVES - Abstract
First-degree relatives (FDRs) of people with rheumatoid arthritis (RA) are increasingly recruited to prediction and prevention studies. Access to FDRs is usually via their proband with RA. Quantitative data on predictors of family risk communication are lacking. RA patients completed a questionnaire assessing likelihood of communicating RA risk information to their FDRs, demographic variables, disease impact, illness perceptions, autonomy preferences, interest in FDRs taking a predictive test for RA, dispositional openness, family functioning, and attitudes towards predictive testing. Ordinal regression examined associations between patients' characteristics and their median likelihood of communicating RA risk to FDRs. Questionnaires were completed by 482 patients. The majority (75.1%) were likely/extremely likely to communicate RA risk information to FDRs, especially their children. Decision-making preferences, interest in FDRs taking a predictive test, and beliefs that risk knowledge would increase people's empowerment over their health increased patients' odds of being likely to communicate RA risk information to FDRs. Beliefs that risk information would cause stress to their relatives decreased odds that patients would be likely to communicate RA risk. These findings will inform the development of resources to support family communication about RA risk. • RA patients were likely to communicate about RA risk to their relatives. • Patients were more likely to communicate RA risk to their children vs siblings. • Preferences for health autonomy/ empowerment increased family risk communication. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.